Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Diagnosis of invasive pneumococcal disease among children in Kenya with enzyme-linked immunosorbent assay for immunoglobulin G antibodies to pneumococcal surface adhesin A.
SCOTT, JA G; Mlacha, Z; Nyiro, J; Njenga, S; Lewa, P; Obiero, J; Otieno, H; Sampson, JS; Carlone, GM;
2005
Clinical and diagnostic laboratory immunology, (2005).12 10 10.1128/CDLI.12.10.1195-1201.2005.
Neonatal BCG protection against tuberculosis lasts for 20 years in Brazil.
Barreto, ML; Cunha, SS; Pereira, SM; Genser, B; Hijjar, MA; Yury Ichihara, M; De Brito, SC; Dourado, I; Cruz, A; Santa'Ana, C; RODRIGUES, LC;
2005
The international journal of tuberculosis and lung disease, (2005).9 10
The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.
Welte, R; Trotter, CL; EDMUNDS, WJ; Postma, MJ; Beutels, P;
2005
PharmacoEconomics, (2005).23 9 10.2165/00019053-200523090-00001.
Modelling the hepatitis B vaccination programme in prisons.
Sutton, AJ; Gay, NJ; EDMUNDS, WJ; Andrews, NJ; HOPE, VD; Gilbert, RL; Piper, M; Gill, ON;
2005
Epidemiology and infection, (2005).134 2 10.1017/S0950268805005182.
Reaching the unreached with measles vaccination.
Salama, P; McFarland, J; MULHOLLAND, K;
2005
Lancet, (2005).366 9488 10.1016/S0140-6736(05)67191-7.
Malaria vaccines. Evaluation and implementation.
GREENWOOD, B;
2005
Acta tropica, (2005).95 3 10.1016/j.actatropica.2005.04.017.
Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
Melegaro, A; EDMUNDS, WJ;
2004
Vaccine, (2004).22 31-32 10.1016/j.vaccine.2004.05.003.
The seroepidemiology of Bordetella pertussis infection in Western Europe.
Pebody, RG; Gay, NJ; Giammanco, A; Baron, S; Schellekens, J; Tischer, A; Olander, RM; Andrews, NJ; EDMUNDS, WJ; Lecoeur, H; Lévy-Bruhl, D; Maple, PA C; De Melker, H; Nardone, A; Rota, MC; Salmaso, S; Conyn-van Spaendonck, MA E; Swidsinski, S; MILLER, E;
2004
Epidemiology and infection, (2004).133 1 10.1017/s0950268804003012.
MMR vaccination and pervasive developmental disorders: a case-control study.
SMEETH, L; Cook, C; Fombonne, E; Heavey, L; RODRIGUES, LC; SMITH, PG; Hall, AJ;
2004
Lancet, (2004).364 9438 10.1016/S0140-6736(04)17020-7.
Use of vaccine trials to estimate burden of disease.
MULHOLLAND, EK;
2004
Journal of health, population, and nutrition, (2004).22 3